James H. Herndon

1938 -

occupation: physician, orthopedian

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 101

Date

Title

Authors

2019-04

Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

Henry Seth Friedman, Annick Desjardins, Allan Friedman, Frances McSherry, Dina Randazzo, Katherine B Peters, James H. Herndon, Eric Lipp, Arliene Ravelo
2018

Adjunctive perampanel for glioma-associated epilepsy

Henry Seth Friedman, Annick Desjardins, Dina Randazzo, Katherine B Peters, James H. Herndon, Eric Lipp, Sarah Woodring, Mallika Weant, Anastasie M Dunn-Pirio
2018-06-26

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, Roger E McLendon, Frances McSherry, Dina Randazzo, Dani Bolognesi, James H. Herndon, Smita K Nair, Matthias Gromeier, Katherine B Peters
2018-04-17

Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.

Henry Seth Friedman, Annick Desjardins, Frances McSherry, James J Vredenburgh, Katherine B Peters, James H. Herndon, Eric Lipp, Mary Lou Affronti
2017-07-01

A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population

Henry Seth Friedman, Annick Desjardins, Frances McSherry, Katherine B Peters, Dina Randazzo, Stephen T Keir, James H. Herndon, Eric Lipp, Mary Lou Affronti, Sarah Woodring, Charlene Flahiff, Janet Minchew
2017-04-01

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

Henry Seth Friedman, Darell D. Bigner, Allan Friedman, Roger E McLendon, James H. Herndon, Robert J Schmittling, Smita K Nair, Duane A Mitchell, Kristen A Batich
2017-11-01

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.

Patrick C Gedeon, Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, Roger E McLendon, Kent J. Weinhold, James H. Herndon, Robert J Schmittling, Kendra L Congdon, Smita K Nair, Duane A Mitchell, Kristen A Batich, Pamela K Norberg, Anastasie M Dunn-Pirio
2017-12-21

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

Eric Lipp, Henry Seth Friedman, Annick Desjardins, David A Reardon, Frances McSherry, Katherine B Peters, James H. Herndon
2017-11-13

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

Henry Seth Friedman, Annick Desjardins, David A Reardon, Frances McSherry, Dina Randazzo, Katherine B Peters, James H. Herndon, Eric Lipp, Woody Massey, Ashley P Ghiaseddin
2016-12-23

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

Henry Seth Friedman, Annick Desjardins, Frances McSherry, James J Vredenburgh, Katherine B Peters, James H. Herndon, Mary Lou Affronti, Sarah Woodring
2016-06-06

Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).

John P. Kirkpatrick, Henry Seth Friedman, Annick Desjardins, Frances McSherry, James J Vredenburgh, Katherine B Peters, James H. Herndon, Mary Lou Affronti, Sarah Woodring
2015-05-29

Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

Henry Seth Friedman, Annick Desjardins, David A Reardon, Frances McSherry, James J Vredenburgh, Katherine B Peters, James H. Herndon, Emil Lou, Eric Lipp
2015-03-11

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

April Coan, Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, David A Reardon, Roger E McLendon, James J Vredenburgh, James H. Herndon, Kendra L Congdon, Smita K Nair, Duane A Mitchell, Kristen A Batich
2015-05-21

Practical Dyspnea Assessment: Relationship Between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity

Nicholas G Wysham, Andrew Wilcock, David C. Currow, Amy P. Abernethy, Gregory P Samsa, James H. Herndon, Benjamin J Miriovsky
2015-11-09

ATCT-01PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)

Henry Seth Friedman, Annick Desjardins, Katherine B Peters, Dina Randazzo, Mary Lou Affronti, James H. Herndon, Eric Lipp, Woody Massey
2015-11-09

ATCT-13BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION: A PHASE II TRIAL

Henry Seth Friedman, Annick Desjardins, Allan Friedman, Dina Randazzo, Katherine B Peters, James H. Herndon, Stevie Threatt, Mallika Weant, Anastasie M Dunn-Pirio
2015-11-09

IMCT-19COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM).

Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, Dina Randazzo, James H. Herndon, Katherine B Peters, Ashley P Ghiaseddin
2015-11-09

QOL-19PROSPECTIVE EVALUATION OF CARDIOPULMONARY FITNESS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING AN ANTI-ANGIOGENIC REGIMEN

Henry Seth Friedman, Annick Desjardins, Frances McSherry, Katherine B Peters, James H. Herndon, Whitney E Hornsby, Eric Lipp, Ashley P Ghiaseddin
2015-11-09

QOL-20LOW-DOSE NALTREXONE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA: PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED PILOT STUDY

Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Frances McSherry, Dina Randazzo, James H. Herndon, Eric Lipp, Katherine B Peters, Mary Lou Affronti, Sarah Woodring, Charlene Flahiff, Janet Minchew
2015-11-09

QOL-21DIET AND HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN THE PRIMARY BRAIN TUMOR POPULATION

Henry Seth Friedman, Annick Desjardins, Frances McSherry, Katherine B Peters, Dina Randazzo, Mary Lou Affronti, James H. Herndon, Eric Lipp, Sarah Woodring, Charlene Flahiff, Janet Minchew
2015-11-09

RTRB-04STEREOTACTIC RADIOSURGERY FOR RECURRENT HIGH-GRADE GLIOMAS: PATIENT SELECTION AND THE ROLE OF BEVACIZUMAB

Henry Seth Friedman, Annick Desjardins, Frances McSherry, Junzo Chino, Katherine B Peters, John P. Kirkpatrick, James H. Herndon, Alvin R Cabrera
2014-03-01

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Henry Seth Friedman, Darell D. Bigner, Allan Friedman, Roger E McLendon, Bill H Diplas, Zachary J Reitman, James H. Herndon, Stephen T Keir, Patrick J Killela, Christopher J Pirozzi, Eric Lipp, Huishan Zhu
2014-08-13

Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients

Henry Seth Friedman, Annick Desjardins, Frances McSherry, Katherine B Peters, April Coan, James H. Herndon, Whitney E Hornsby, Emily Waner
2014-11-01

AT-20SINGLE INSTITUTION RETROSPECTIVE REVIEW OF PERFORMANCE STATUS AND CORTICOSTEROID USE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS (PTS) TREATED ON BEVACIZUMAB (BEV)

Henry Seth Friedman, Annick Desjardins, Allan Friedman, Frances McSherry, Katherine B Peters, James H. Herndon, Eric Lipp, Arliene Ravelo
2014-11-01

AT-21FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM)

Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, Frances McSherry, James H. Herndon, Eric Lipp, Denise Lally-Goss, Matthias Gromeier, Katherine B Peters, Stevie Threatt
2014-07-01

ONCOLYTIC POLIOVIRUS IMMUNOTHERAPY OF GLIOBLASTOMA

Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Michael C Brown, James H. Herndon, Elena Dobrikova, Mikhail I Dobrikov, Matthias Gromeier, Stevie Threatt, Karen Carter
2014-07-01

ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN RECURRENT GLIOBLASTOMA (GBM): FIRST PHASE I CLINICAL TRIAL EVALUATING THE INTRATUMORAL ADMINISTRATION

Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, Frances McSherry, James H. Herndon, Denise Lally-Goss, Matthias Gromeier, Katherine B Peters, Stevie Threatt, Tulika Ranjan
2014-11-01

QL-21SPIRITUAL WELL-BEING AND ITS ASSOCIATION WITH HEALTH-RELATED QUALITY OF LIFE IN PRIMARY BRAIN TUMOR PATIENTS

Henry Seth Friedman, Annick Desjardins, Frances McSherry, Dina Randazzo, Katherine B Peters, Mary Lou Affronti, James H. Herndon, Eric Lipp, Sarah Woodring, Charlene Flahiff, Janet Minchew, Tulika Ranjan
2014-11-01

IT-34PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)

Henry Seth Friedman, Darell D. Bigner, Annick Desjardins, Allan Friedman, James H. Herndon, Denise Lally-Goss, Katherine B Peters, Kristen A Batich, Tulika Ranjan
2014-11-01

QL-20PROGNOSTIC IMPORTANCE OF HEALTH-RELATED QUALITY OF LIFE AND FATIGUE IN NEWLY DIAGNOSED GLIOBLASTOMA

Henry Seth Friedman, Annick Desjardins, Frances McSherry, Dina Randazzo, Katherine B Peters, Mary Lou Affronti, James H. Herndon, Eric Lipp, Sarah Woodring, Charlene Flahiff, Janet Minchew, Tulika Ranjan
2014-11-01

AT-19SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE

Henry Seth Friedman, Annick Desjardins, Allan Friedman, Frances McSherry, Katherine B Peters, James H. Herndon, Eric Lipp, Arliene Ravelo
2013-01-24

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

Henry Seth Friedman, Annick Desjardins, David A Reardon, James J Vredenburgh, Katherine B Peters, April Coan, James H. Herndon, Leighann Bailey, Emil Lou, Ashley L Sumrall, Eric Lipp

Human - wd:Q112381232

Welcome to Inventaire

the library of your friends and communities

learn more